SIGHT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Gensight Biologics SA

Watchlist Manager

Watchlist

Price: 0.1062 EUR -2.39% Market Closed

Market Cap: €25m

	Gensight Biologics SA PAR:SIGHT	FR
D	Dino Polska SA WSE:DNP	PL
	Pointerra Ltd OTC:PTRRF	AU
	Kirin Holdings Co Ltd F:KIR0	JP
C	Comcast Corp XMUN:CTP2	US
B	Boundless Bio Inc NASDAQ:BOLD	US
	Companhia Energetica do Rio Grande do Norte Cosern BOVESPA:CSRN3	BR
	iSpecimen Inc NASDAQ:ISPC	US
E	Eason & Co PCL SET:EASON	TH
	Protagenic Therapeutics Inc NASDAQ:PTIX	US

Profitability Summary

Gensight Biologics SA's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1 105 400%

Negative 3Y Average Operating Margin

-223 644%

Declining Operating Margin

-1 088% > -1 105 400%

Negative Net Margin

-1 203 600%

Negative 3Y Average Net Margin

-243 150%

Declining Net Margin

-959% > -1 203 600%

Negative Free Cash Flow Margin

-917 400%

Negative 3Y Average Free Cash Flow Margin

-185 009%

Declining Free Cash Flow Margin

-808% > -917 400%

Exceptional ROE

46%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-1 101%

Declining ROIC

-820% > -1 192%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.